Dengvaxia | search
Click here to view Dengvaxia news from 60+ newspapers.
Bookmark or Share- Vaccines and immunization: Dengue - World Health Organization (WHO)10 May 2024 | Q&A. What types of dengue vaccines are available? What is Dengvaxia® (CYD-TDV)? What is Qdenga® (TAK-003)? What are WHO’s recommendations related to TAK-003? What is the definition of high dengue transmission intensity? Who should not get a dengue vaccine?
- Dengue vaccine - WikipediaDengvaxia is a weakened but live vaccine and works by triggering an immune response against four types of dengue virus. Dengvaxia became commercially available in 2016 in 11 countries: Mexico, the Philippines, Indonesia, Brazil, El Salvador, Costa Rica, Paraguay, Guatemala, Peru, Thailand, and Singapore.
- DENGVAXIA | FDA - U.S. Food and Drug AdministrationFor the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4. DENGVAXIA is approved for use in individuals 6 through 16 years of age with laboratory-confirmed previous...
- Dengvaxia: the world’s first vaccine for prevention of secondary dengueDengvaxia is the brand name for chimeric yellow fever-dengue-tetravalent dengue vaccine (CYD-TDV), manufactured by Sanofi Pasteur (Paris, France), and is the first and only of its kind that has been licensed for use in 19 countries, but is only available in 10. 2 Several phase II and phase III studies have led to particular vaccination limitatio...
- Dengue Vaccine | Dengue | CDCAbout Dengvaxia. Dengvaxia is the only dengue vaccine approved by the U.S. Food and Drug Administration and recommended for routine use by the Advisory Committee on Immunization Practices. It is made by Sanofi Pasteur. The vaccine prevents dengue caused by all four dengue virus serotypes. Since 2022, Dengvaxia has been available for use in ...
More
